Report Store Get Proposal

Home Blog Notizia 36

Notizia - Recent Pharma, Healthcare and Biotech Happenings

MedTech-News-updates-Eclipse-Medtronic-Aethlon-Cognoa-ObvioHealth

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Eclipse, Medtronic, Aethlon, Cognoa, ObvioHealth, and others Continue to Veer MedTech Market Forward

Eclipse Launches MicroPen EVO™ Advanced Micro-needling Device On June 01, 2021, Eclipse, a leading aesthetic and medical manufacturer, received FDA clearance of their latest medical-grade micro-needling device, the MicroPen EVO. It had launched MicroPen EVO in Canada last year and now will make it available to dermatology and aesthetic practices in the United States. Tom O'Brien, CEO, and Founder of Eclipse said, “We are very excited to announce the FDA clearance of the MicroPen EVO. This represents the start of multigenerational product offerings that will propel Eclipse for many years to come." Eclipse first entered the micro-needling device industry...

Explore More...

alzheimer's

Lilly remunerates AC Immune; Akero adds $70M; Ra Pharma $100M

patent ductus arteriosus

Notizia

alzheimer's

Roche signs Icagen; UCB devote $255M; Siemens Healthineers celebrates

Johnson & Johnson

Notizia

vedanta

Prometic bags $50M; Vedanta receives $12M; Humira biosimilar deal

Cambrex acquires Avista; Sobi pays $50M; LEO Pharma signs deal; Boston Scientific remunerates

patent ductus arteriosus

Notizia

Synthorx needs IPO; Deerfield puts up $80M; SVB remunerates; Celgene’s deal

glaxosmithkline

Notizia

TNBC Triple Negative Breast Cancer

Triple Negative Breast Cancer

Sanofi

Gordon and Betty Moore Foundation gives $85M; Omeicos raises; Sanofi signs deal; Lilly grabs

Cholera vaccine delivered; Rice-inspired breakthroughs; International partnerships

FDA

FDA approves Zulresso; Pfizer receives approval; Novartis relinquishes Rituxan

Gilead

Gilead remunerates; Roche taps Halozyme’s drug delivery tech; Orchard Therapeutics prices its IPO

Hot flashes

Notizia

Gilead

Innovent Biologics reaps; Jeff Aronin’s lead; Alexion gives out; Stoke Therapeutics receives

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly